Cancer is a systemic disease producing a variety of biochemical and morphological changes in organs remote from the primary growth (Begg, 1958 (Stewart, Snell, Dunham and Schlyen, 1959) .
The investigation was divided into three parts. In the first two parts the test rats had tumours induced by injecting, without anaesthetic, a sterile suspension of 200,000 viable Walker 256 tumour cells into the subcutaneous tissues of a hind limb using a 20-gauge needle. The techniques used in the preparation of this inoculate resemble those described by Rodin, Tumer and Couves (1963 Both groups were starved for 24 hours and the fasting blood sugar level for each rat was then determined on a 0-2 ml. sample of blood withdrawn, without anaesthetic, from a tail vein. Blood sugar levels were estimated by Nelson's modification of the Somogyi method (Nelson, 1944 (Fig. 1) . No transition period of decreasing liver glycogen concentration was noted for the tumour bearing rats. Up to the 8th day of tumour growth, the liver glycogen stores were apparently normal but immediately thereafter, the glycogen concentration fell sharply away and this state persisted for the rest of the experimental period.
Part II No significant difference was found between the fasting blood sugar values for the control group of rats and the rats bearing 15-day-old tumours. The mean fasting blood sugar for the former group was 69 ± 4-9 mg.% (± I S.D.) while the latter group had a mean fasting blood sugar of 70 ± 3-6 mg.%.
The glucagon effect 2 hours after a single intraperitoneal injection of glucose on the blood sugar of control, non-tumour bearing, rats and rats with 15-day-old tumours is shown graphically in Fig. 2 . Immediately preceding the glucagon injections, the mean blood sugar for the control rats was 87 ± 4-7 mg.% and the mean blood sugar for the tumour bearing rats was 107 ± 3.6 mg.%. after the glucagon injections the mean blood sugar of the control group was 115 ± 6-3 mg.% and the mean blood sugar for the tumour bearing rats was 114 ± 1.8 mg.%. The mean blood sugar for the control rats had fallen to 104 ± 9 -2 mg. % I 0 minutes later while at this time the mean blood sugar of the tumour bearing rats had fallen to 107 ± 3-8 mg.%. The elevation in blood sugar noted after the glucagon injection in both groups of rats is due entirely to the breakdow-n of liver glycogen to glucose which is then released into the circulation. Glucagon has no effect on muscle glycogen.
Part III
Metastatic tumours, when present, were found only in the liver, no other organ being involved in any of the rats in either group.
Two animals in the group of rats starved for 24 hours before the injection of Of the 35 rats starved before tumour cell injection, only 11 were found to be free from cancer. Of the remaining 24, 17 had extensive liver tumours. The group of rats maintained on a normal diet and given a supplementary injection of glucose had, by comparison, a reduced incidence of liver tumour formation. Twenty-three of the 36 rats were free from liver cancer and only two of the remaining rats had extensive tumour deposits in the liver.
DISCUSSION
The results of the first two experiments show that the Walker 256 carcinoma, growing at a site remote from the liver, has an inhibiting effect on liver glycogen synthesis after about 8 days of tumour growth. Using a technique of total liver glycogen assay, Young, Kensler, Seki and Homburger (1947) found a similar effect in mice made host to the experimental Sarcoma 180. We do not believe that this decrease in glycogen concentration results from reflex glycogenolysis consequent upon the rapid removal of sugar from the blood by the growing cancer cell population as has been suggested by Seay and Rosenkrantz (1965) . Had this been the explanation, we would expect to find a significant difference in fasting blood sugar levels between control rats and tumour bearing rats. In this investigation we were unable to demonstrate any such difference in the 24 hours fasting blood sugar levels between these two groups. One of the remote, or systemic, effects of cancer is to alter significantly liver enzyme systems (Begg, 1958) 
